National Academy of Sciences Elects Prof. Michael N. Hall as a New Member
The biochemist, Prof. Michael N. Hall from the Biozentrum of the University of Basel, has been elected as member of the National Academy of Sciences (NAS) in recognition of his significant research contributions in the field of cell biology. With his discovery of the regulatory protein TOR (Target of Rapamycin) he uncovered fundamental mechanisms of cell growth and cancer development. Joining the ranks of the NAS is one of the greatest honors to be bestowed on a scientist.
Michael N. Hall, Professor at the Biocenter of the University of Basel, was elected on April 29th, 2014, by the United States National Academy of Sciences to become a new member. Besides Hall, 104 further scientists including 21 foreign nonvoting associates from 15 countries received the distinction this year for their outstanding and pioneering achievements.
Hall began his research at the Biozentrum 27 years ago as a young assistant professor and discovered the enzyme “Target of Rapamycin”, TOR for short, at the institute in 1991. Supported by a Synergy Grant from the European Research Council (ERC), Hall, together with three other scientists from the University of Basel and the ETH Zurich, are currently studying what happens in cells, when tumors become resistant to cancer drugs.
The NAS was founded as early as 1863 and is one of the organizations comprising the United States National Academies. The sole criterion for nomination is scientific excellence. Since this year’s election, the NAS membership totals 2214 active and 444 nonvoting foreign associate members, amongst them some 200 Nobel Prize laureates.
The full press release by the University of Basel is available here.